2018
TCT-432 FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final Results
Bouras G, Abizaid A, Lutz M, Carrie D, Weber-Albers J, Dudek D, Gambone L, Anderson J, Lansky A. TCT-432 FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final Results. Journal Of The American College Of Cardiology 2018, 72: b174. DOI: 10.1016/j.jacc.2018.08.1597.Peer-Reviewed Original ResearchFollow
2017
TCT-806 12-Month Angiographic and Clinical Follow up of the Fantom Sirolimus-eluting Bioresorbable Scaffold
Bouras G, Abizaid A, Carrie D, Frey N, Lutz M, Weber-Albers J, Dudek D, Chevalier B, Cristea E, Lansky A. TCT-806 12-Month Angiographic and Clinical Follow up of the Fantom Sirolimus-eluting Bioresorbable Scaffold. Journal Of The American College Of Cardiology 2017, 70: b328. DOI: 10.1016/j.jacc.2017.09.1016.Peer-Reviewed Original Research
2011
COMPARISON OF LONG TERM CLINICAL PROGNOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ACCORDING TO THE PRESENCE OF IN-HOSPITAL MAJOR BLEEDING EVENTS: 3 YEAR FOLLOW-UP RESULT OF HORIZONS-AMI
Suh J, Mehran R, Dangas G, Claessen B, Parise H, Lansky A, Witzenbichler B, Grines C, Guagliumi G, Kornowski R, Wohrle J, Dudek D, Weisz G, Stone G. COMPARISON OF LONG TERM CLINICAL PROGNOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ACCORDING TO THE PRESENCE OF IN-HOSPITAL MAJOR BLEEDING EVENTS: 3 YEAR FOLLOW-UP RESULT OF HORIZONS-AMI. Journal Of The American College Of Cardiology 2011, 57: e1075. DOI: 10.1016/s0735-1097(11)61075-9.Peer-Reviewed Original ResearchIMPACT OF ASPIRIN DOSE ON LONG TERM CLINICAL OUTCOMES AFTER STENTING FOR ACUTE MYOCARDIAL INFARCTION: 3-YEAR FOLLOW-UP DATA FROM THE HORIZONS-AMI TRIAL
Kovacic J, Mehran R, Dangas G, Claessen B, Parise H, Fahy M, Lansky A, Witzenbichler B, Grines C, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Stone G. IMPACT OF ASPIRIN DOSE ON LONG TERM CLINICAL OUTCOMES AFTER STENTING FOR ACUTE MYOCARDIAL INFARCTION: 3-YEAR FOLLOW-UP DATA FROM THE HORIZONS-AMI TRIAL. Journal Of The American College Of Cardiology 2011, 57: e1633. DOI: 10.1016/s0735-1097(11)61633-1.Peer-Reviewed Original Research
2004
Long term clinical follow up of the phase III randomized trial (START) evaluating the role of beta radiation for the treatment of in stent restenosis
Suntharalingam M, Silber S, Popma J, Speiser B, Lansky A, Teirstein P, Kuntz R, Bonan R. Long term clinical follow up of the phase III randomized trial (START) evaluating the role of beta radiation for the treatment of in stent restenosis. International Journal Of Radiation Oncology • Biology • Physics 2004, 60: s242-s243. DOI: 10.1016/j.ijrobp.2004.07.005.Peer-Reviewed Original ResearchLong term clinical follow up of the phase III randomized trial (START) evaluating the role of beta radiation for the treatment of in stent restenosis
SUNTHARALINGAM M, SILBER S, POPMA J, SPEISER B, LANSKY A, TEIRSTEIN P, KUNTZ R, BONAN R. Long term clinical follow up of the phase III randomized trial (START) evaluating the role of beta radiation for the treatment of in stent restenosis. International Journal Of Radiation Oncology • Biology • Physics 2004, 60: s242-s243. DOI: 10.1016/s0360-3016(04)01268-4.Peer-Reviewed Original Research
1999
Quantitative angiographic analysis of stent restenosis in the scripps coronary radiation to inhibit intimal proliferation post stenting (SCRIPPS) trial
Lansky A, Popma J, Massullo V, Jani S, Russo R, Schatz R, Steuterman S, Guarneri E, Wu H, Mehran R, Mintz G, Leon M, Teirstein P. Quantitative angiographic analysis of stent restenosis in the scripps coronary radiation to inhibit intimal proliferation post stenting (SCRIPPS) trial. The American Journal Of Cardiology 1999, 84: 410-414. PMID: 10468078, DOI: 10.1016/s0002-9149(99)00325-2.Peer-Reviewed Original ResearchConceptsStent marginsStenting TrialStent restenosisIr-192Quantitative angiographic resultsQuantitative angiographic analysisLower restenosis ratePercent diameter stenosisLower relative riskPlacebo sourcesAngiographic resultsRestenosis rateDiameter stenosisAngiographic analysisRelative riskRestenosisTreatment lengthIridium-192Successful interventionsTrialsFurther studiesPatientsTreatmentStenosisFollow